(Q40606325)

22 September 2017

Activating BRAF and N-Ras mutations in sporadic primary melanomas: an inverse association with allelic loss on chromosome 9. (English)

1 reference

22 September 2017

2

1 reference

22 September 2017

Rajiv Kumar

1

0 references

Kari Hemminki

series ordinal

3

object named as

Kari Hemminki

1 reference

PubMed ID

14681681

22 September 2017

language of work or name

English

0 references

publication date

1 December 2003

1 reference

22 September 2017

1 reference

22 September 2017

22

1 reference

22 September 2017

9217-9224

1 reference

22 September 2017

58

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.onc.1206909

22 September 2017

0 references

cites work

Geographical variation in the penetrance of CDKN2A mutations for melanoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206909

Ras mediates the cAMP-dependent activation of extracellular signal-regulated kinases (ERKs) in melanocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206909

Malignant melanoma: modern black plague and genetic black box.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206909

Mutations of the BRAF gene in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206909

Analysis of N- and K-ras mutations in the distinctive tumor progression phases of melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206909

p16INK4a expression is frequently decreased and associated with 9p21 loss of heterozygosity in sporadic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206909

The pathogenesis of melanoma induced by ultraviolet radiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206909

The regulation of normal melanocyte proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206909

Ras redux: rethinking how and where Ras acts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206909

Meaningful relationships: the regulation of the Ras/Raf/MEK/ERK pathway by protein interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206909

Selective deletion of exon 1 beta of the p19ARF gene in metastatic melanoma cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206909

High frequency of BRAF mutations in nevi

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206909

A genome-based strategy uncovers frequent BRAF mutations in melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206909

Recent advances in melanoma research

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206909

The INK4a/ARF locus and melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206909

Understanding Ras: 'it ain't over 'til it's over'.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206909

A pivotal role for ERK in the oncogenic behaviour of malignant melanoma?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206909

UV-induced N-ras mutations are T-cell targets in human melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206909

Pathways to melanoma development: lessons from the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206909

Childhood sun exposure as a risk factor for melanoma: a systematic review of epidemiologic studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206909

Genetic dissection of melanoma pathways in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206909

Activation of B-Raf kinase requires phosphorylation of the conserved residues Thr598 and Ser601.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206909

RAF/RAS oncogenes and mismatch-repair status

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206909

Frequency of UV-inducible NRAS mutations in melanomas of patients with germline CDKN2A mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206909

7 January 2021

N-ras mutations are common in melanomas from sun-exposed skin of humans but rare in mucosal membranes or unexposed skin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206909

7 January 2021

Mutations in the CDKN2A ( p16INK4a ) gene in microdissected sporadic primary melanomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206909

7 January 2021

Mutations in BRAF and KRAS characterize the development of low-grade ovarian serous carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206909

7 January 2021

Increased frequency of LOH on chromosome 9 in sporadic primary melanomas is associated with increased patient age at diagnosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206909

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1206909

1 reference

PubMed ID

14681681

Dimensions Publication ID

22 September 2017

0 references

1 reference

PubMed ID

14681681